Verastem (VSTM) Other Accumulated Expenses (2011 - 2026)
Verastem (VSTM) recorded quarterly Other Accumulated Expenses of $3.1 million in Q1 2026, up 4.15% quarter-over-quarter from $3.0 million in Q4 2025, and up 653.0% on a YoY basis from $417000.0 in Q1 2025.
Verastem (VSTM) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Verastem's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 653.0% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 653.0% YoY), while the FY2025 annual figure was $3.0 million, up 121.85% from the prior year.
- Other Accumulated Expenses was $3.1 million for Q1 2026 at Verastem, up from $3.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $12.6 million in Q2 2022 to a low of $183000.0 in Q2 2025.
- Historically, Other Accumulated Expenses has averaged $2.4 million across 5 years, with a median of $1.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses jumped 1087.11% in 2022, then plunged 91.85% in 2023.
- A 5-year view of Other Accumulated Expenses shows it stood at $996000.0 in 2022, then grew by 4.72% to $1.0 million in 2023, then surged by 30.3% to $1.4 million in 2024, then surged by 121.85% to $3.0 million in 2025, then advanced by 4.15% to $3.1 million in 2026.
- The last three Other Accumulated Expenses figures came in at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 417,000.00 |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 688,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 9.05 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 943,000.00 |
| Dec 31, 2022 | 996,000.00 |
| Sep 30, 2022 | 921,000.00 |
| Jun 30, 2022 | 12.62 Mn |
| Mar 31, 2022 | 914,000.00 |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 999,000.00 |
| Jun 30, 2021 | 1.06 Mn |